Experience

SiteOne Therapeutics to Be Acquired by Eli Lilly for up to $1 Billion

May 28, 2025

Cooley advised SiteOne Therapeutics, a private biotechnology company developing small molecule inhibitors of sodium channels to treat pain and other neuronal hyperexcitability disorders, on its acquisition by Eli Lilly.

Read more

Related contacts

Laura Berezin
Partner, Seattle
Sara Semnani
Partner, Santa Monica
Rowook Park
Partner, San Diego
Charity Williams
Partner, San Diego
Rena Kaminsky
Special Counsel, Palo Alto
Todd Gluth
Partner, San Diego
Lila Hope
Partner, Palo Alto
Noel Ripberger-Scheick
Associate, Palo Alto
Tucker Cochenour
Associate, Palo Alto
Kristin O'Hanlon
Special Counsel, San Francisco
David Fletcher
Partner, Washington, DC
Jamie Leigh
Partner, San Francisco
Carly Mitchell
Partner, Washington, DC
Jeremy Morrison
Partner, Washington, DC
Gerard O'Shea
Partner, New York
Marty Schenker
Senior Counsel , San Francisco
Chen Chen
Special Counsel, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Selin Akkan
Associate, Palo Alto
Mari Dugas
Associate, Washington, DC
Virat Gupta
Associate, Washington, DC
Joseph J. Kim
Associate, Palo Alto
Eileen Leman
Associate, Los Angeles
Ehijele Olumese
Associate, Santa Monica
Joseph Perry
Associate, Reston
Hannah Rausch
Associate, New York
Melody Van Horn
Senior Paralegal, Palo Alto

Related Practices & Industries

Admissions and credentials

New York